VeriMompiper methysticum leaf/root/stem extract est-il sûr pendant la grossesse ?
No EU Annex II/III ban or harmonised CLP H‑codes were identified. CIR reviewed Piper methysticum extracts and concluded available data were insufficient to support safety for cosmetic use; clinical and case reports raise concerns about systemic effects (hepatotoxicity, neonatal effects) after ingestion, and there is limited/uncertain information about placental/fetal transfer — therefore a class/compound concern is present but no harmonised H361/H360 evidence. Sources: CIR final report (2009), case literature.
Alternatives sûres à piper methysticum leaf/root/stem extract pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- piper methysticum leaf/root/stem extract est-il sûr pendant la grossesse ?
- No EU Annex II/III ban or harmonised CLP H‑codes were identified. CIR reviewed Piper methysticum extracts and concluded available data were insufficient to support safety for cosmetic use; clinical and case reports raise concerns about systemic effects (hepatotoxicity, neonatal effects) after ingestion, and there is limited/uncertain information about placental/fetal transfer — therefore a class/compound concern is present but no harmonised H361/H360 evidence. Sources: CIR final report (2009), case literature.
- piper methysticum leaf/root/stem extract est-il sûr pendant l'allaitement ?
- No regulatory restriction (Annex II/III) or harmonised CLP classification found. Public health guidance and case reports note that kava constituents can be transmitted to breastmilk or are of concern for breastfeeding; CIR judged data insufficient for cosmetic safety but raised questions about constituents (kavalactones). This supports a class‑level concern and demonstrated potential for transfer (m=2) but not a confirmed harmonised reproductive hazard. Exposure from topical cosmetic use is expected to be low.
- piper methysticum leaf/root/stem extract est-il sûr pour la peau de bébé ?
- No infant‑specific harmonised classification or EU ban; however kava contains bioactive kavalactones and case reports of neonatal dermatologic effects after maternal exposure exist. Mechanistic evidence of bioactivity (CNS/liver effects) supports m=2. Topical exposure in infants has higher absorption (immature skin) so exposure score increased by +1 versus adult. No data showing infant‑topical harm at cosmetic concentrations, but data gaps remain.
- Comment VeriMom évalue-t-il piper methysticum leaf/root/stem extract ?
- VeriMom évalue piper methysticum leaf/root/stem extract à 60/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à piper methysticum leaf/root/stem extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à piper methysticum leaf/root/stem extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.